Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon Deficiency”

107 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 107 results

Early research (Phase 1)Study completedNCT00796770
What this trial is testing

Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

Who this might be right for
HIV
Baylor Research Institute 19
Not applicableStudy completedNCT00002018
What this trial is testing

Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects

Who this might be right for
HIV Infections
Interferon Sciences 60
Testing effectiveness (Phase 2)Study completedNCT00196586
What this trial is testing

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Who this might be right for
HIV InfectionsChronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 75
Not applicableStudy completedNCT05478018
What this trial is testing

Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus ErythematosusInterferon Deficiency
Rigshospitalet, Denmark 55
Large-scale testing (Phase 3)Study completedNCT01939197
What this trial is testing

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 318
Early research (Phase 1)UnknownNCT03588715
What this trial is testing

Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)

Who this might be right for
HIVHIV/AIDSHIV-1 Infection
Luis Montaner 15
Not applicableStudy completedNCT00947609
What this trial is testing

Improving Latent Tuberculosis (TB) Diagnosis in Thai Children

Who this might be right for
Latent TuberculosisHIV Infections
SEARCH Research Foundation 158
Post-approval studies (Phase 4)Study completedNCT01285050
What this trial is testing

Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds

Who this might be right for
HIV InfectionHepatitis C
Johns Hopkins University 20
Early research (Phase 1)Study completedNCT00000857
What this trial is testing

Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableStudy completedNCT00002299
What this trial is testing

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Post-approval studies (Phase 4)Ended earlyNCT01147042
What this trial is testing

Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease

Who this might be right for
IFN-Gamma TherapyCGD Gene MutationCGD Response to IFNg+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 2
Testing effectiveness (Phase 2)Study completedNCT01295515
What this trial is testing

Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT00000967
What this trial is testing

The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Study completedNCT05104723
What this trial is testing

Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications

Who this might be right for
Chronic Granulomatous DiseaseInflammatory Gastrointestinal DiseaseInflammatory Skin Disease+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00005012
What this trial is testing

Safety and Effectiveness of PEG-Intron in HIV-Infected Patients

Who this might be right for
HIV Infections
Schering-Plough 250
Early research (Phase 1)Study completedNCT00001113
What this trial is testing

AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)Study completedNCT00140725
What this trial is testing

Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 160
Large-scale testing (Phase 3)Study completedNCT01482767
What this trial is testing

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 262
Post-approval studies (Phase 4)Ended earlyNCT00687544
What this trial is testing

Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)

Who this might be right for
Hepatitis C, ChronicHepacivirusHIV Infections
Merck Sharp & Dohme LLC 11
Post-approval studies (Phase 4)Study completedNCT00553930
What this trial is testing

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

Who this might be right for
Hepatitis C, ChronicHIV Infections
Sociedad Andaluza de Enfermedades Infecciosas 71
Next Page